Review
Open access
Oct 2026
Dual-targeting theranostic strategies to overcome receptor heterogeneity in neuroendocrine prostate cancer.
The complementary expression profiles of PSMA, GRPR, and NTSR1 provide a strong rationale for developing dual-targeted theranostic platforms capable of overcoming tumor heterogeneity and lineage plasticity of advanced PC.
Satyam Dewangan, Boga Vijay Kumar, N. Meher
· RSC Medicinal Chemistry · 0 citations